• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对肝移植受者进行头颈部癌症监测可实现早期诊断:一项监测计划的回顾性分析

Surveillance of head and neck cancer in liver transplant recipients allows an early diagnosis: a retrospective analysis of a surveillance program.

作者信息

Zambrano Ivan, Alcalde Juan, Iñarrairaegui Mercedes, Rotellar Fernando, Herrero J Ignacio

机构信息

Department of Internal Medicine, School of Medicine, Universidad de Navarra, Pamplona, Spain.

Othorhinolaringology Department, Clínica Universidad de Navarra, Pamplona, Spain.

出版信息

Front Oncol. 2025 Mar 13;15:1465123. doi: 10.3389/fonc.2025.1465123. eCollection 2025.

DOI:10.3389/fonc.2025.1465123
PMID:40182044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11966391/
Abstract

INTRODUCTION

head and neck cancer is a common and severe complication than can occur after liver transplantation. However, it is unclear whether surveillance can help detect and prevent this type of cancer in liver transplant recipients.

PATIENTS AND METHODS

We retrospectively examined 119 transplanted patients who had a smoking history above 20 pack-years. These patients underwent yearly evaluations by an ear-nose-throat specialist.

RESULTS

Twelve of them (10.1%) were diagnosed with head and neck cancer. The most significant risk factor for developing head and neck cancer was having been transplanted for alcoholic liver disease. Of the 12 diagnosed cases, six cases were diagnosed at an early-intermediate stage (stages 0-II), five were at an advanced stage (including one patient who was diagnosed at his first surveillance visit and two who did not attend the surveillance visits), and tumor stage was unknown in one case. Three patients had cancer recurrences, all of them had continued smoking after their initial diagnosis. The five-year actuarial survival rate after the diagnosis of head and neck cancer was 65.6%.

DISCUSSION

Annual surveillance for head and neck cancer may allow for early diagnosis and better survival rates after cancer diagnosis.

摘要

引言

头颈癌是肝移植后可能出现的一种常见且严重的并发症。然而,目前尚不清楚监测是否有助于在肝移植受者中检测和预防这类癌症。

患者与方法

我们回顾性研究了119例有超过20包年吸烟史的移植患者。这些患者每年接受耳鼻喉科专家的评估。

结果

其中12例(10.1%)被诊断为头颈癌。发生头颈癌最显著的危险因素是因酒精性肝病接受移植。在这12例确诊病例中,6例在早中期(0-II期)被诊断,5例处于晚期(包括1例在首次监测就诊时被诊断以及2例未参加监测就诊的患者),1例肿瘤分期未知。3例患者出现癌症复发,他们在初次诊断后均继续吸烟。头颈癌诊断后的五年精算生存率为65.6%。

讨论

对头颈癌进行年度监测可能有助于早期诊断并提高癌症诊断后的生存率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060e/11966391/7deea5a56cd6/fonc-15-1465123-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060e/11966391/49625a692026/fonc-15-1465123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060e/11966391/0f84f43cbe1f/fonc-15-1465123-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060e/11966391/7deea5a56cd6/fonc-15-1465123-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060e/11966391/49625a692026/fonc-15-1465123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060e/11966391/0f84f43cbe1f/fonc-15-1465123-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/060e/11966391/7deea5a56cd6/fonc-15-1465123-g003.jpg

相似文献

1
Surveillance of head and neck cancer in liver transplant recipients allows an early diagnosis: a retrospective analysis of a surveillance program.对肝移植受者进行头颈部癌症监测可实现早期诊断:一项监测计划的回顾性分析
Front Oncol. 2025 Mar 13;15:1465123. doi: 10.3389/fonc.2025.1465123. eCollection 2025.
2
Head and neck cancer after liver transplantation in the north of Spain.西班牙北部肝移植后的头颈癌
ANZ J Surg. 2025 Apr 21. doi: 10.1111/ans.70133.
3
De Novo Head and Neck Cancer After Liver Transplant With Antibody-Based Immunosuppression Induction.肝移植后采用基于抗体的免疫抑制诱导治疗出现的新发头颈部癌
Transplant Proc. 2018 Dec;50(10):3661-3666. doi: 10.1016/j.transproceed.2018.06.033. Epub 2018 Jun 30.
4
Incidence and long-term survival of patients with de novo head and neck carcinoma after liver transplantation.肝移植术后新发头颈部癌患者的发病率及长期生存率
Head Neck. 2016 May;38(5):707-14. doi: 10.1002/hed.23943. Epub 2015 Jun 25.
5
Head and neck cancer in living donor liver transplant recipients: Single center retrospective study.活体肝移植受者的头颈癌:单中心回顾性研究。
Medicine (Baltimore). 2019 Aug;98(31):e16701. doi: 10.1097/MD.0000000000016701.
6
De novo head and neck cancer arising in solid organ transplantation recipients: The Asan Medical Center experience.实体器官移植受者新发头颈部癌:峨山医学中心的经验。
Auris Nasus Larynx. 2018 Aug;45(4):838-845. doi: 10.1016/j.anl.2017.11.006. Epub 2017 Nov 14.
7
Head and neck cancer screening in patients eligible for liver transplantation.头颈部癌症筛查在适合肝移植的患者中进行。
Acta Otorrinolaringol Esp (Engl Ed). 2020 Jul-Aug;71(4):249-252. doi: 10.1016/j.otorri.2020.02.003. Epub 2020 May 17.
8
Alcoholism: independent predictor of survival in patients with head and neck cancer.酗酒:头颈癌患者生存的独立预测因素。
J Natl Cancer Inst. 1996 Apr 17;88(8):542-9. doi: 10.1093/jnci/88.8.542.
9
Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review.肝移植受者新发恶性肿瘤的风险因素和发生率:系统评价。
Liver Int. 2010 Oct;30(9):1247-58. doi: 10.1111/j.1478-3231.2010.02303.x.
10
Challenges in transplantation for alcoholic liver disease.酒精性肝病移植面临的挑战。
World J Gastroenterol. 2014 Jul 7;20(25):8033-9. doi: 10.3748/wjg.v20.i25.8033.

本文引用的文献

1
Tacrolimus Drug Exposure Level and Smoking Are Modifiable Risk Factors for Early Malignancy After Liver Transplantation for Alcohol-Related Liver Disease.他克莫司药物暴露水平和吸烟是酒精性肝病肝移植后早期恶性肿瘤的可改变危险因素。
Transpl Int. 2024 Feb 19;37:12055. doi: 10.3389/ti.2024.12055. eCollection 2024.
2
Smoking, Drinking, and Dietary Risk Factors for Head and Neck Cancer in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Participants.前列腺癌、肺癌、结直肠癌和卵巢癌筛查试验参与者中,吸烟、饮酒和饮食风险因素与头颈部癌症的关系。
JAMA Otolaryngol Head Neck Surg. 2024 Mar 1;150(3):249-256. doi: 10.1001/jamaoto.2023.4551.
3
Evaluation of ear, nose, and throat-screening in liver transplantation candidates: A retrospective cohort study.
评估肝移植候选者的耳鼻咽喉筛查:一项回顾性队列研究。
Transpl Infect Dis. 2024 Feb;26(1):e14226. doi: 10.1111/tid.14226. Epub 2023 Dec 27.
4
Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients.低剂量 CT 和 FDG-PET 在肝移植受者中筛查肺癌。
Liver Transpl. 2023 Oct 1;29(10):1100-1108. doi: 10.1097/LVT.0000000000000121. Epub 2023 Mar 20.
5
Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation.肝移植后他克莫司的累积暴露量与癌症发生率
Am J Transplant. 2022 Jun;22(6):1671-1682. doi: 10.1111/ajt.17021. Epub 2022 Mar 31.
6
De Novo Malignancy After Liver Transplantation: Risk Assessment, Prevention, and Management-Guidelines From the ILTS-SETH Consensus Conference.肝移植后新发恶性肿瘤:风险评估、预防和管理——ILTS-SETH 共识会议指南。
Transplantation. 2022 Jan 1;106(1):e30-e45. doi: 10.1097/TP.0000000000003998.
7
Individual head and neck screening: Initiating a dialogue about best approach.个体头颈部筛查:探讨最佳方法。
Am J Otolaryngol. 2022 Mar-Apr;43(2):103302. doi: 10.1016/j.amjoto.2021.103302. Epub 2021 Dec 3.
8
Reexamining Rates of Decline in Lung Cancer Risk after Smoking Cessation. A Meta-analysis.重新审视戒烟后肺癌风险下降率:一项荟萃分析
Ann Am Thorac Soc. 2020 Sep;17(9):1126-1132. doi: 10.1513/AnnalsATS.201909-659OC.
9
Head and neck cancer screening in patients eligible for liver transplantation.头颈部癌症筛查在适合肝移植的患者中进行。
Acta Otorrinolaringol Esp (Engl Ed). 2020 Jul-Aug;71(4):249-252. doi: 10.1016/j.otorri.2020.02.003. Epub 2020 May 17.
10
Head and neck cancer in living donor liver transplant recipients: Single center retrospective study.活体肝移植受者的头颈癌:单中心回顾性研究。
Medicine (Baltimore). 2019 Aug;98(31):e16701. doi: 10.1097/MD.0000000000016701.